Woodley Trial Solutions is an ISO 9001:2015 certified global supplier of clinical trial equipment and ancillary services, established in 1989. With offices in Bolton (UK), Brooklyn (USA), and Tilburg (Netherlands), we supply equipment, POCT devices, CGM solutions, digital health technology, and Site-Ready Patient Kits to CROs, pharma, and biotech companies in over 100 countries.
Developing a network of suppliers and service providers around the globe, Woodley Trial Solutions has successfully grown, establishing a reputation for consistently providing quality and reliable equipment services. Our ISO 9001:2015 certification, membership of the Institute of Clinical Research (ICR), and Clinical Contract Research Association (CCRA) reflect our commitment to quality management and best practice across the clinical trials industry.
Our commitment to the clinical trials industry goes beyond the provision of equipment services and as such we are proud to be members of both the Institute of Clinical Research and the Clinical Contract Research Association.
Specialist Teams… Deliver a Special Service
Our team includes dedicated project managers, logistics specialists, biomedical scientists, and medical electronics engineers. Providing a responsive, end-to-end global service from first enquiry through to study close-out.
Our solutions and services have impact
For the health of humanity
Woodley Trial Solutions has supported hundreds of global clinical trials across therapeutic areas including oncology, diabetes, cardiovascular, and rare diseases. Helping life-saving medications reach patients faster.
What motivates clinical trial patients motivates us; helping to make life-saving medications available to the world. We are focused on supporting these amazing people to step up and make a difference against disease through successful trials. Getting groundbreaking equipment into their lives as quickly as possible to let the data flow and make their contribution matter faster.
We are driven to increase innovation and expand our reach to narrow the gap between clinical trials and world-changing treatments.